NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹77 Cr | ₹34 Cr | ₹32 Cr | ₹30 Cr | ₹16 Cr |
What is the latest Total Debt ratio of NGL FINECHEM ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹77 Cr |
| Mar2024 | ₹34 Cr |
| Mar2023 | ₹32 Cr |
| Mar2022 | ₹30 Cr |
| Mar2021 | ₹16 Cr |
How is Total Debt of NGL FINECHEM Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹77 Cr | 126.73 | |
| Mar2024 | ₹34 Cr | 4.63 | |
| Mar2023 | ₹32 Cr | 8.32 | |
| Mar2022 | ₹30 Cr | 82.41 | |
| Mar2021 | ₹16 Cr | - | |
Compare Total Debt of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹812.3 Cr | -0.3% | -6% | -30.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,768.0 Cr | -2.7% | -2.2% | -0.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,385.0 Cr | -0.7% | -1.1% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,242.0 Cr | -0.8% | 0.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹121,093.0 Cr | -1.2% | -1.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,799.0 Cr | NA | 2.4% | 0.2% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -0.3% |
-6% |
-30.6% |
| SENSEX | -0.4% |
-0.2% |
2.9% |
You may also like the below Video Courses